View all services

02 December 2016 • Articles


Laboratory Corporation of America Holdings and Sequenom, Inc.

Laboratory Corporation of America Holdings (LabCorp(R)) (NYSE:LH), the world’s leading healthcare diagnostics company, and Sequenom, Inc. (NASDAQ: SQNM), a pioneer in non-invasive prenatal testing (NIPT) for reproductive health, today announced that they have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of approximately $371 million, including net indebtedness.

Morrow Sodali is acting as Information Agent on this merger.

Click here to request documents for this deal.

For further inquiries
Contact us
Contact us

Please complete this form to be contacted by a Morrow Sodali representative.